Must have a life expectancy of at least 10 years based on age and comorbidities but excluding diagnosis of breast cancer.
Histologically or cytologically proven diagnosis of breast cancer with evidence of metastasis.
Histological diagnosis of breast cancer
Pathologically proven diagnosis of breast cancer
Current diagnosis of bilateral breast cancer
History of radiotherapy for current breast cancer diagnosis
Diagnosis of breast malignancy
Stage at diagnosis T2 through T4a-c, N0 through N2, and M0; patients with inflammatory breast cancer or metastatic disease at diagnosis will be excluded; patients with multicentric, multifocal, and/or bilateral disease are allowed to participate so long as all tumors meet the histologic criteria of the study
Subjects with confirmed diagnosis of recurrent or metastatic breast cancer based on histopathology examination
Patients should have a life expectancy of at least 10 years, excluding their diagnosis of breast cancer; (comorbid conditions should be taken into consideration, but not the diagnosis of breast cancer)
diagnosis of HR+, HER2+ breast cancer (BC)
Confirmed diagnosis of HR+/HER2- breast cancer
Have a diagnosis of HR+, HER2- breast cancer.
Have a diagnosis of HR+, HER2- breast cancer
Pathologically confirmed diagnosis of breast cancer with documented progressive disease
Current diagnosis of bilateral breast cancer
Current diagnosis of any other active or clinically significant non-breast cancer
Pathologically confirmed diagnosis of breast cancer (central confirmation is not required)
Have a diagnosis of breast cancer and be chemotherapy naive; NOTE: prior methotrexate for non-cancerous conditions is allowed
Post-menopausal patients at breast cancer (BC) diagnosis, as determined locally
Diagnosis of other active malignancy; prior treated malignancies in addition to breast cancer are acceptable
PATIENT: Confirmed medical diagnosis of breast or thoracic cancer regardless of stage and followed at DCC for management
New breast cancer diagnosis
Stage IV breast cancer diagnosis (metastases remote from the breast)
Recent diagnosis of breast cancer with pending surgery as primary treatment for breast cancer
Confirmed first diagnosis of stage IV breast cancer or a recurrent diagnosis of metastatic breast cancer (MBC) (i.e., spread to distant organs), any time since diagnosis
Patient must be an Asian American who has had a breast cancer diagnosis in the past 5 years
Primary diagnosis of breast cancer (initial or recurrence) within the last two years
Have a diagnosis of stage I-III female breast cancer or colorectal cancer within the past 5 years; bilateral or multiple primary breast cancers are permitted; individuals who have had more than one type of cancer (e.g., both breast and melanoma) are permitted as long as the breast (or colorectal) diagnosis meets the other criteria and primary treatment for any cancer is not ongoing
YOUNG BREAST CANCER SURVIVORS (YBCS): Breast cancer (Stages 0-III) diagnosis
YBCS: Breast cancer diagnosis age ? 45 years
Patients who have a diagnosis of breast cancer
Patients with a recurrent breast cancer diagnosis
A diagnosis of local regional breast cancer (stage 0-IIIa)
Had a previous diagnosis of breast cancer (any type or stage) as confirmed by official medical records
Have a diagnosis of prostate, breast, lung, lymphoma, or gynecological cancer
Have a previous diagnosis of breast cancer
New diagnosis of breast cancer stage 1-2
Histologically confirmed stage I, II or III breast cancer (if the patient has had more than one breast cancer diagnosis, then the most recent diagnosis)
Primary diagnosis of breast cancer within the last three years
PHASE I: Has a first, primary diagnosis of unilateral stage 0, 1, 2, or 3a breast cancer (patients with bilateral breast cancer will be excluded from participation)
Diagnosis of stage IV breast cancer or recurrent metastatic breast cancer
Diagnosis of metastatic breast cancer
Diagnosis of recurrent breast cancer
Diagnosis of breast cancer with adjuvant chemotherapy treatment
Stage 1A â€“ 2B breast cancer diagnosis
Diagnosis of breast cancer
Diagnosis of HER2-positive breast cancer
History of a diagnosis of breast cancer
Breast cancer diagnosis within past 5 years
Have a confirmed diagnosis of breast cancer; participants can have had more than one primary cancer diagnosis in the past
Have a diagnosis of breast cancer, any stage.
Women initially diagnosed with breast cancer by histological tissue diagnosis in 2003 or later
Prior breast cancer or DCIS diagnosis
Patients with known diagnosis of breast cancer
Have a prior diagnosis of T1 or T2 breast cancer diagnosed within the last 10 years
History of prior breast cancer treated within the past two years; patients completing all breast cancer-specific treatment over two years prior to the current diagnosis are eligible
COHORT B: No prior diagnosis of breast cancer but at high risk for development of breast cancer and participating in HSC 4601
Diagnosis of breast cancer
Pathologically confirmed diagnosis of HER2 positive breast cancer of any stage (previous treatment is allowed without limits on lines of prior therapy)
Previous history or current diagnosis of breast cancer
Patients with a previous diagnosis of invasive breast cancer who are less than 3 years from diagnosis
Life expectancy of at least 5 years, excluding diagnosis of breast cancer (comorbid conditions should be taken into consideration, but breast cancer diagnosis is not a consideration)
Diagnosis of stage I-IIIA breast cancer within past 5 years (confirmed by medical record review)
New diagnosis of breast cancer
The patient must have a histologically proven diagnosis of stage I through IIIC breast cancer
Pathologic diagnosis of invasive breast cancer or high suspicion of breast cancer based on imaging
with a suspicious lesion found in the breast and recommended for biopsy or have a confirmed diagnosis of cancer;
Women who have undergone open surgical (excisional) biopsy for breast cancer diagnosis
Patients must have a current diagnosis of sarcoma, lymphoma, or HER2(-) breast cancer
Patients with a prior breast cancer diagnosis
Pregnant at the time of diagnosis of their breast cancer.
Diagnosis of primary breast cancer.
